Farmacocinética y farmacodinamia de los antibióticos en el paciente críticamente enfermo. Primera parte

Angus, 2001, Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care, Crit Care Med., 29, 1303, 10.1097/00003246-200107000-00002 Vincent, 2009, International study of the prevalence and outcomes of infection in intensive care units, JAMA, 302, 2323, 10.1001/jama.2009.1754 Mohd, 2015, Pharmacokinetic/Pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development, Semin Respir Crit Care Med, 36, 136, 10.1055/s-0034-1398490 Curcio, 2013, Antibiotic prescription in critically ill patients: A Latin American experience, Ann Med Health Sci Res, 3, 220, 10.4103/2141-9248.113666 Rodríguez, 2011, The epidemiology of sepsis in Colombia: A prospective multicenter cohort study in ten university hospitals, Crit Care Med, 39, 1675, 10.1097/CCM.0b013e318218a35e Ortiz, 2014, Epidemiología de sepsis en unidades de cuidado intensivo en Colombia, Biomédica, 34, 40, 10.7705/biomedica.v34i1.1439 Dellinger, 2013, Surviving sepsis campaign guidelines committee including the pediatric subgroup, Crit Care Med., 41, 580, 10.1097/CCM.0b013e31827e83af Kumar, 2006, Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock, Crit Care Med., 34, 1589, 10.1097/01.CCM.0000217961.75225.E9 Pea, 2009, Bencho to bedside review: Appropriate antibiotic therapy in sever sepsis and septic shock–does the dose matter?, Crit Care, 13, 214, 10.1186/cc7774 Rello, 2005, Pneumonia caused by oxacillin resistant Staphylococcus aureus treated with glycopeptides, Crit Care Med, 33, 1983, 10.1097/01.CCM.0000178180.61305.1D Blot, 2005, MRSA pneumonia: Better outcome through continuous infusion of vancomycin?, Crit Care Med, 33, 2127, 10.1097/01.CCM.0000178288.70057.47 Scaglione, 2009, Appropriate use of antimicrobials: The peculiarity of septic patients, Int J Antimicrob Agents., 34, S52, 10.1016/S0924-8579(09)70568-0 McKenzie, 2011, Antibiotic dosing in critical illness, J Antimcrob Chemoter., 66, ii25 Roberts, 2012, How to optimize antimicrobial prescriptions in the Intensive Care Unit: principles of individualized dosing pharmacokinetics and pharmacodynamics, Int J Antimicrob Agets., 39, 187, 10.1016/j.ijantimicag.2011.11.002 Joung Mk, 2011, Impact of de–escalation therapy on clinical outcomes for intensive care unit–acquired pneumonia, Crit Care., 15, R79, 10.1186/cc10072 Goncalves-Pereira, 2013, Dose modulation: A new concept of antibiotic therapy in the critically ill patient?, J Crit Care., 10.1016/j.jcrc.2012.11.018 Pea, 2006, The antimicrobial therapy puzzle: could pharmacokinetic–pharmacodynamics relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?, Clin Infect Dis., 42, 1764, 10.1086/504383 Smith, 2012, Introduction to drug pharmacokinetics in the critically ill patient, Chest, 141, 1327, 10.1378/chest.11-1396 Varghese, 2011, Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically i l l with severe sepsis and septic shock, Crit Care Clin, 27, 19, 10.1016/j.ccc.2010.09.006 Craig W.A, Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics, Ed. Springer. 2014. Alexander A. Vinks, Hartmut Derendorf, Johan W. Mouton Editors. Craig, 1998, Pharmacokinetic/pharmacodynamics parameters: rationale for antibacterial dosing of mice and men, Clin Infect Dis., 26, 1, 10.1086/516284 Ambrose, 2007, Pharmacokinetics–pharmacodynamics of antimicrobial therapy: it's not just for mice anymore, Clin Infect Dis., 44, 79, 10.1086/510079 Eagle, 1950, The effective concentrations of penicillin in vitro and in vivo for streptococci, pneumococci, and Treponema pallidum, J Bacteriol, 59, 625, 10.1128/JB.59.5.625-643.1950 Eagle, 1950, Effect of schedule of administration on the therapeutic efficacy of penicillin; importance of the aggregate time penicillin remains at effectively bactericidal levels, Am J Med, 9, 280, 10.1016/0002-9343(50)90425-6 Eagle, 1953, Continuous vs. discontinuous therapy with penicillin: the effect of the interval between injections on therapeutic efficacy, N Engl J Med, 248, 481, 10.1056/NEJM195303192481201 Shah, 1976, Dosis–Wirkungs–Beziehung der Bakterizidie Bei E. coli, K. Pneumoniae und Staphylococcus aureus, Dtsch Med Wochenschr, 101, 325, 10.1055/s-0028-1104083 Goncalves-Pereira, 2011, Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β–lactams, Crit Care., 15, R206, 10.1186/cc10441 Scaglione, 2008, Pharmacokinetics/pharmacodynamics of antibacterials in intensive care unit: Setting appropriate dosing regimens, Int J. Antimicrob Agents., 32, 294, 10.1016/j.ijantimicag.2008.03.015